ATEA PHARMACEUTICALS INC (AVIR) Top Institutional Shareholders

ATEA PHARMACEUTICALS INC (AVIR) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $308.71M in AVIR holdings during the latest filing period.

Fmr Llc is currently the largest disclosed institutional shareholder of AVIR tracked by InsiderSet, reporting ownership valued at approximately $64.30M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $51.75M, representing an estimated loss of -19.52% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 77% of the total disclosed AVIR value among the investors covered in this analysis. Major shareholders include Fmr Llc, Blackrock, Inc., Bml Capital Management, Llc, and several other long-term asset managers with concentrated positions in ATEA PHARMACEUTICALS INC (AVIR).

This page ranks the largest institutional AVIR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

125

Total Reported Value

$308.71M

Largest Holder

Fmr Llc

Largest Position

$64.30M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

139

Funds Exiting Positions

0

Page 1 of 3
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Fmr Llc0.00%11,950,772$64,295,153$51,746,843-$12,548,310-19.52%
Blackrock, Inc.0.00%8,435,437$45,382,652$36,525,442-$8,857,210-19.52%
Bml Capital Management, Llc24.43%7,058,657$37,975,575$30,563,985-$7,411,590-19.52%
Tang Capital Management Llc1.32%4,814,700$25,903,086$20,847,651-$5,055,435-19.52%
Vanguard Capital Management Llc0.00%3,246,124$17,464,147$14,055,717-$3,408,430-19.52%
Bain Capital Life Sciences Investors, Llc1.15%2,360,638$12,700,232$10,221,563-$2,478,669-19.52%
Two Sigma Investments, Lp0.01%1,864,164$10,029,202$8,071,830-$1,957,372-19.52%
Geode Capital Management, Llc0.00%1,747,706$9,405,012$7,567,567-$1,837,445-19.54%
State Street Corp0.00%1,694,635$9,117,136$7,337,770-$1,779,366-19.52%
Dimensional Fund Advisors Lp0.00%1,255,484$6,752,650$5,436,246-$1,316,404-19.49%
Rosalind Advisors, Inc.2.58%1,171,855$6,304,580$5,074,132-$1,230,448-19.52%
Renaissance Technologies LLCJim Simons0.01%1,166,400$6,275,232$5,050,512-$1,224,720-19.52%
Morgan Stanley0.00%731,020$3,932,891$3,165,317-$767,574-19.52%
Charles Schwab Investment Management Inc0.00%596,709$3,210,294$2,583,750-$626,544-19.52%
Goldman Sachs Group Inc0.00%588,463$3,165,931$2,548,045-$617,886-19.52%
Northern Trust Corp0.00%585,025$3,147,435$2,533,158-$614,277-19.52%
Vanguard Portfolio Management Llc0.00%557,579$2,999,775$2,414,317-$585,458-19.52%
Vanguard Fiduciary Trust Co0.00%484,705$2,607,713$2,098,773-$508,940-19.52%
Jane Street Group, Llc0.00%418,296$2,250,432$1,811,222-$439,210-19.52%
D. E. Shaw & Co., Inc.0.00%379,314$2,040,710$1,642,430-$398,280-19.52%
Cm Management, Llc1.60%355,000$1,909,900$1,537,150-$372,750-19.52%
Millennium Management Llc0.00%349,932$1,882,634$1,515,206-$367,428-19.52%
Banque Pictet & Cie Sa0.02%345,077$1,856,514$1,494,183-$362,331-19.52%
Opaleye Management Inc.0.23%322,600$1,735,588$1,396,858-$338,730-19.52%
Irenic Capital Management Lp0.15%301,699$1,623,141$1,306,357-$316,784-19.52%
Peapod Lane Capital Llc1.18%272,820$1,442,958$1,181,311-$261,647-18.13%
Hsbc Holdings Plc0.00%258,989$1,380,411$1,121,422-$258,989-18.76%
Nuveen, Llc0.00%243,103$1,307,894$1,052,636-$255,258-19.52%
Arrowstreet Capital, Limited Partnership0.00%210,542$1,132,716$911,647-$221,069-19.52%
Bank Of New York Mellon Corp0.00%185,805$999,631$804,536-$195,095-19.52%
Auour Investments Llc0.30%177,000$952,260$766,410-$185,850-19.52%
American Century Companies Inc0.00%167,230$899,697$724,106-$175,591-19.52%
Barclays Plc0.00%160,946$865,889$696,896-$168,993-19.52%
Bnp Paribas Financial Markets0.00%156,391$841,384$677,173-$164,211-19.52%
Sei Investments Co0.00%156,384$841,346$677,143-$164,203-19.52%
Bridgeway Capital Management, Llc0.02%148,400$798,392$642,572-$155,820-19.52%
Invesco Ltd.0.00%133,348$717,412$577,397-$140,015-19.52%
Point72 Asset Management, L.P.0.00%119,553$643,195$517,664-$125,531-19.52%
Informed Momentum Co Llc0.07%112,866$607,219$488,710-$118,509-19.52%
Ubs Group Ag0.00%109,950$591,531$476,084-$115,448-19.52%
Bank Of America Corp0.00%105,640$568,343$457,421-$110,922-19.52%
State Of Wisconsin Investment Board0.00%99,803$536,940$432,147-$104,793-19.52%
Strs Ohio0.00%96,400$518,632$417,412-$101,220-19.52%
Jump Financial, Llc0.01%93,247$501,669$403,760-$97,909-19.52%
Aldebaran Capital, Llc0.37%89,946$483,909$389,466-$94,443-19.52%
Rhumbline Advisers0.00%89,054$479,101$385,604-$93,497-19.52%
Susquehanna International Group, Llp0.00%81,835$440,272$354,346-$85,926-19.52%
Alliancebernstein L.P.0.00%121,320$433,112$525,316+$92,204+21.29%
Nomura Asset Management International Inc.0.00%70,000$377,000$303,100-$73,900-19.60%
Deutsche Bank Ag\0.00%65,686$353,391$284,420-$68,971-19.52%

Frequently asked questions about AVIR

  • Who owns the most AVIR stock?

    The largest holders of AVIR are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ATEA PHARMACEUTICALS INC (AVIR).

  • Is AVIR widely held by superinvestors?

    Many widely followed stocks like AVIR appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AVIR is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.